Intuitive Surgical, Inc. logo

Intuitive Surgical, Inc. (ISRG)

Market Closed
5 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
575. 34
+6.71
+1.18%
$
205.13B Market Cap
76.32 P/E Ratio
0% Div Yield
1,058,417 Volume
5.59 Eps
$ 568.63
Previous Close
Day Range
569.43 576.88
Year Range
425 616
Want to track ISRG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 46 days
Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now

Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now

Johnson & Johnson hasn't performed that well in the past decade. By contrast, Vertex Pharmaceuticals and Intuitive Surgical have been exceptional.

Fool | 1 year ago
Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?

Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

Zacks | 1 year ago
3 AI Stocks That You Can Buy and Hold Forever

3 AI Stocks That You Can Buy and Hold Forever

If you are looking for AI-related stocks you can buy and hold forever, look no further than this list. The stocks on this list are applying AI, and the application of AI counts.

Marketbeat | 1 year ago
What Are the Hottest AI Stocks Right Now? 3 Top Picks

What Are the Hottest AI Stocks Right Now? 3 Top Picks

As I'm sure everyone reading this is aware, artificial intelligence, or AI, has been quite a volatile sector in the recent past. All indicators suggest this will continue in the near to semi-long-term future.

Investorplace | 1 year ago
Is Intuitive Surgical Stock a Buy?

Is Intuitive Surgical Stock a Buy?

Intuitive Surgical has an impressive international growth opportunity with hospitals. Growth and valuation expansion have combined to fuel investment returns.

Fool | 1 year ago
Should Investors Worry About These 7 Words From Intuitive Surgical's CEO?

Should Investors Worry About These 7 Words From Intuitive Surgical's CEO?

Intuitive Surgical's procedure volume in one key category is declining. However, the medical device specialist continues to record excellent financial results.

Fool | 1 year ago
Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet

Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks | 1 year ago
Bull of the Day: Intuitive Surgical (ISRG)

Bull of the Day: Intuitive Surgical (ISRG)

Double digit growth is back for the maker of da Vinci.

Zacks | 1 year ago
Intuitive Surgical, Inc. (ISRG) is a Great Momentum Stock: Should You Buy?

Intuitive Surgical, Inc. (ISRG) is a Great Momentum Stock: Should You Buy?

Does Intuitive Surgical, Inc. (ISRG) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 1 year ago
Are Medical Stocks Lagging Intuitive Surgical (ISRG) This Year?

Are Medical Stocks Lagging Intuitive Surgical (ISRG) This Year?

Here is how Intuitive Surgical, Inc. (ISRG) and biote Corp. (BTMD) have performed compared to their sector so far this year.

Zacks | 1 year ago
Intuitive Surgical (ISRG) Hits All-Time High: Will It Go Higher?

Intuitive Surgical (ISRG) Hits All-Time High: Will It Go Higher?

Shares of Intuitive Surgical ISRG surged 9.3% last Friday, after the company announced second-quarter results. The share price touched an all-time high of $456.81 and also closed at a record high of $455.01.

Zacks | 1 year ago
Intuitive Surgical Stock Outperforms Market: Highs on the Horizon

Intuitive Surgical Stock Outperforms Market: Highs on the Horizon

Intuitive Surgical's NASDAQ: ISRG stock bucked the broad-market selloff because of its operational quality, performance, outlook, and balance sheet, which has absolutely nothing wrong with it. The B/S highlights for Q2 include a 490 basis point increase in cash and securities and the net cash position.

Marketbeat | 1 year ago
Loading...
Load More